State of Wyoming Purchases 1,080 Shares of Axon Enterprise, Inc $AXON

State of Wyoming increased its position in Axon Enterprise, Inc (NASDAQ:AXON) by 426.9% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,333 shares of the biotechnology company’s stock after buying an additional 1,080 shares during the quarter. State of Wyoming’s holdings in Axon Enterprise were worth $747,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. ABN AMRO Bank N.V. raised its holdings in Axon Enterprise by 107.7% during the 2nd quarter. ABN AMRO Bank N.V. now owns 1,080 shares of the biotechnology company’s stock valued at $604,000 after buying an additional 560 shares during the last quarter. Russell Investments Group Ltd. grew its holdings in Axon Enterprise by 38.3% in the 2nd quarter. Russell Investments Group Ltd. now owns 145,209 shares of the biotechnology company’s stock worth $79,947,000 after acquiring an additional 40,214 shares during the last quarter. WPG Advisers LLC increased its position in shares of Axon Enterprise by 108.5% in the second quarter. WPG Advisers LLC now owns 269 shares of the biotechnology company’s stock valued at $151,000 after acquiring an additional 140 shares during the period. Mitsubishi UFJ Trust & Banking Corp raised its stake in shares of Axon Enterprise by 6.0% during the second quarter. Mitsubishi UFJ Trust & Banking Corp now owns 93,914 shares of the biotechnology company’s stock valued at $52,649,000 after acquiring an additional 5,300 shares during the last quarter. Finally, Meridian Wealth Management LLC raised its stake in shares of Axon Enterprise by 24.5% during the second quarter. Meridian Wealth Management LLC now owns 971 shares of the biotechnology company’s stock valued at $544,000 after acquiring an additional 191 shares during the last quarter. 79.08% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In related news, insider Elizabeth Reid Coughlin sold 1,554 shares of Axon Enterprise stock in a transaction dated Thursday, June 4th. The shares were sold at an average price of $485.00, for a total transaction of $753,690.00. Following the completion of the transaction, the insider directly owned 34,024 shares of the company’s stock, valued at $16,501,640. This trade represents a 4.37% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, President Joshua Isner sold 13,000 shares of the business’s stock in a transaction dated Friday, June 5th. The stock was sold at an average price of $488.45, for a total transaction of $6,349,850.00. Following the sale, the president directly owned 169,125 shares in the company, valued at $82,609,106.25. The trade was a 7.14% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 68,989 shares of company stock worth $36,016,932 over the last 90 days. Corporate insiders own 4.20% of the company’s stock.

Axon Enterprise Stock Performance

AXON opened at $612.83 on Monday. The stock has a market cap of $49.79 billion, a PE ratio of 254.29, a PEG ratio of 9.95 and a beta of 1.39. The company has a quick ratio of 1.80, a current ratio of 2.15 and a debt-to-equity ratio of 0.47. The business has a 50 day moving average of $526.06 and a 200-day moving average of $473.48. Axon Enterprise, Inc has a 52 week low of $339.01 and a 52 week high of $794.29.

Axon Enterprise (NASDAQ:AXON) last released its quarterly earnings results on Tuesday, August 4th. The biotechnology company reported $1.88 earnings per share for the quarter, beating the consensus estimate of $1.84 by $0.04. Axon Enterprise had a return on equity of 2.84% and a net margin of 6.19%.The company had revenue of $904.39 million for the quarter, compared to analyst estimates of $876.42 million. During the same period in the previous year, the company posted $2.12 earnings per share. The firm’s revenue was up 35.3% on a year-over-year basis. Equities research analysts predict that Axon Enterprise, Inc will post 2.04 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on the company. Barclays raised their target price on Axon Enterprise from $523.00 to $688.00 and gave the stock an “overweight” rating in a research note on Thursday, August 6th. Morgan Stanley upped their price target on Axon Enterprise from $600.00 to $640.00 and gave the company an “overweight” rating in a research report on Thursday, August 6th. JPMorgan Chase & Co. lifted their price objective on Axon Enterprise from $750.00 to $755.00 and gave the stock an “overweight” rating in a research report on Thursday, May 7th. Royal Bank Of Canada reissued an “outperform” rating on shares of Axon Enterprise in a research note on Tuesday, July 21st. Finally, Piper Sandler upped their target price on Axon Enterprise from $724.00 to $732.00 and gave the company an “overweight” rating in a report on Thursday, August 6th. Thirteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $730.92.

Key Headlines Impacting Axon Enterprise

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Axon reported quarterly earnings of $1.88 per share, exceeding the $1.84 consensus estimate, while revenue reached $904.4 million versus expectations of $876.4 million. Revenue increased 35.3% year over year, reinforcing the growth outlook for its public-safety technology, connected devices and software businesses. Axon Enterprise stock in focus after strong quarter
• Positive Sentiment: A Motley Fool article highlighted Axon as a category leader that continues to deliver double-digit revenue growth despite trading below its prior high, supporting the case for long-term investors willing to hold the stock for a decade. Two stocks to buy and hold for the next decade
• Positive Sentiment: Northland Securities raised its FY2027 EPS forecast to $6.49 from $5.53 and increased estimates for the first three quarters of 2027. The firm also lifted its Q3 2026 estimate to $1.01 from $0.85, signaling stronger anticipated earnings momentum beyond the current year.
• Neutral Sentiment: Northland’s revisions were mixed: it reduced its FY2026 EPS forecast to $3.12 from $3.26 and lowered Q4 2026 expectations to $1.29 from $1.55, while raising several 2027 forecasts. This suggests near-term execution concerns but improved longer-term expectations.
• Negative Sentiment: AXON’s valuation remains demanding, with a reported price-to-earnings ratio above 250 and a PEG ratio near 10. Strong growth is already reflected in the share price, leaving the stock vulnerable to profit-taking or disappointment if future results do not exceed elevated expectations.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.